Successful Living-Donor Liver Transplantation for Cholestatic Liver Failure Induced by Allopurinol: Case Report.
暂无分享,去创建一个
H. Goto | Yoji Ishizu | M. Ishigami | Y. Ogura | Y. Onishi | H. Kamei | Keiichi Yamada | Y. Ishizu | H. Imai | H. Goto | K. Yamada | Yasuhiro Ogura
[1] S. Miederer,et al. Allopurinol-Hypersensitivitätssyndrom: Lebertransplantation nach Behandlung einer asymptomatischen Hyperurikämie , 2014, Deutsche Medizinische Wochenschrift.
[2] L. Stamp. Safety profile of anti-gout agents: an update , 2014, Current opinion in rheumatology.
[3] J. Talwalkar,et al. Drug-induced liver injury. , 2014, Mayo Clinic proceedings.
[4] H. S. Dhaliwal,et al. Acute liver failure. , 2014, The New England journal of medicine.
[5] B. Phillips,et al. Safety and Efficacy of Allopurinol in Chronic Kidney Disease , 2013, The Annals of pharmacotherapy.
[6] Y. Cho,et al. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. , 2013, Journal of the American Academy of Dermatology.
[7] Y. Takikawa,et al. Etiology and prognosis of fulminant hepatitis and late‐onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009 , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.
[8] C. Thorn,et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen‐B Genotype and Allopurinol Dosing , 2013, Clinical pharmacology and therapeutics.
[9] C. Yeung,et al. Association between HLA‐B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong , 2012, The British journal of dermatology.
[10] Yoshiro Saito,et al. [Trends in drug-induced liver injury based on reports of adverse reactions to PMDA in Japan]. , 2012, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences.
[11] Y. Takikawa,et al. Diagnostic criteria of acute liver failure: A report by the Intractable Hepato‐Biliary Diseases Study Group of Japan , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.
[12] J. Roujeau,et al. The DRESS syndrome: a literature review. , 2011, The American journal of medicine.
[13] A. M. Vieira,et al. DRESS syndrome: a case report and literature review , 2011, BMJ Case Reports.
[14] R. Fontana,et al. Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop , 2010, Hepatology.
[15] A. Matsui,et al. Re‐evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[16] 草野 浩治,et al. AASLD position paper: the management of acute liver failure (特集 救急診療ガイドライン) -- (海外のガイドライン) , 2008 .
[17] A. Markel,et al. Allopurinol-Induced Recurrent DRESS Syndrome: Pathophysiology and Treatment , 2008, Renal failure.
[18] S. Russmann,et al. Lebensbedrohliche Nebenwirkungen der Gichtbehandlung , 2004 .
[19] S. Russmann,et al. [Life-threatening adverse effects of pharmacologic antihyperuricemic therapy]. , 2004, Therapeutische Umschau. Revue therapeutique.
[20] A. Gimson,et al. Late-onset hepatic failure: clinical features, serology and outcome following transplantation. , 1995, Journal of hepatology.
[21] G. Danan,et al. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.
[22] Roger Williams,et al. Acute liver failure: redefining the syndromes , 1993, The Lancet.
[23] A. Gimson,et al. Late onset hepatic failure: Clinical, serological and histological features , 1986, Hepatology.